Kinhikar, Arvind and Valentin, Marie-Anne (2024) Recommendations for Development and Validation of a Fit-For-Purpose Biomarker Assays Using Western Blotting; An-AAPS Sponsored Initiative to Harmonize Industry Practices. The AAPS journal, 26 (5). p. 87. ISSN 1550-7416

Abstract

Western blot (WB) assays are routinely used for detection and quantification of biomarkers. Although assay validation to measure biomarkers in complex matrices has become a mainstay process for ligand binding assays (LBA) and mass spectrometry (MS), no guidelines exist yet validate biomarker methods using WB techniques. In this cross-industry white paper, we outlined in detail the key steps for development and for validation of WB assays for protein biomarkers under different contexts of use (COU). In addition, we described how to determine the level of assay validation needed for biomarker assays using Western blotting. For simplicity, we described two paths of WB assay validation. The first path (Path 1) is for biomarkers being analyzed for exploratory research or for internal go- or no/go- decision making. The second path (Path 2) is for clinical decision making such as dose determination or drug response that need to be run in a regulated environment. This work is supported through AAPS Biomarkers and Precision Medicine subteam and represents AAPS members opinion.

Item Type:	Article
Keywords:	Biomarkers Humans Blotting, Western Drug Industry Reproducibility of Results
Date Deposited:	13 Aug 2024 00:45
Last Modified:	13 Aug 2024 00:45
URI:	https://oak.novartis.com/id/eprint/52376